315 related articles for article (PubMed ID: 8480793)
1. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
Hendeles L; Hochhaus G; Kazerounian S
Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
[No Abstract] [Full Text] [Related]
2. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
Kefalas CH; Ciociola AA
Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
[No Abstract] [Full Text] [Related]
3. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
4. Lawsuits anticipated on generic biologicals front.
Fox JL
Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
[No Abstract] [Full Text] [Related]
5. The generic drug approval process.
Rheinstein PH
Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
[No Abstract] [Full Text] [Related]
6. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
Heller WM
Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
[No Abstract] [Full Text] [Related]
7. Evaluating the bioavailability and bioequivalence of generic medications.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
[TBL] [Abstract][Full Text] [Related]
8. When is a "generic" medication not really a generic?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
[TBL] [Abstract][Full Text] [Related]
9. What makes a generic medication generic?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
[TBL] [Abstract][Full Text] [Related]
10. Generic drug approval: a US perspective.
Nagori BP; Mathur V; Garg S
Curr Med Res Opin; 2011 Mar; 27(3):541-5. PubMed ID: 21219120
[TBL] [Abstract][Full Text] [Related]
11. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
Rostron A
Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
[TBL] [Abstract][Full Text] [Related]
12. Trying times for generic medicines in the USA.
Lancet; 2013 Mar; 381(9872):1072. PubMed ID: 23540840
[No Abstract] [Full Text] [Related]
13. Multinational medicines--ensuring drug quality in an era of global manufacturing.
Okie S
N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
[No Abstract] [Full Text] [Related]
14. What's the problem with generic antiepileptic drugs?: a call to action.
Berg MJ
Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
[No Abstract] [Full Text] [Related]
15. Current regulatory and legal considerations for follow-on biologics.
Kingham RF; Lietzan E
Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
[No Abstract] [Full Text] [Related]
16. Generic substitution: issues for problematic drugs.
Henderson JD; Esham RH
South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
[TBL] [Abstract][Full Text] [Related]
17. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
Bongiorno RA; Nutescu EA
Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
[TBL] [Abstract][Full Text] [Related]
18. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
Cohen J
Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
[No Abstract] [Full Text] [Related]
19. Wellbutrin versus generic bupropion.
Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
[No Abstract] [Full Text] [Related]
20. Generic drugs.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 May; (IB61):1-18. PubMed ID: 12807116
[No Abstract] [Full Text] [Related]
[Next] [New Search]
